Shawn Lupold

Has grant

The Catherine Iola and J. Smith Michael Distinguished Professor of Urology

Johns Hopkins University School of Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Shawn Lupold is the Catherine Iola and J. Smith Michael Distinguished Professor of Urology at The Johns Hopkins University School of Medicine in the United States. His research focuses on prostate cancer, including genetic factors, tumor microenvironment alterations, and innovative therapeutic approaches. Recent publications highlight his investigations into biomarkers, therapeutic targets, and the growth dynamics of prostate cancer xenografts.

Recent Grants

Grant: Open

SPORE in Prostate Cancer

Open Date: 2024-09-01

Close Date: 2029-08-31

Grant: Close

Society for Basic Urology Research 2022 Fall Meeting: Complex Cells, Systems and Regulatory Pathways In Urologic Biology

Open Date: 2022-09-15

Close Date: 2023-09-14

Grant: Close

Role of Homeobox C Gene Cluster in Castration-Resistant Prostate Cancer

Open Date: 2021-09-01

Close Date: 2025-08-31

Grant: Close

The Immunologic Role of miR-21 in the Prostate Cancer Tumor Microenvironment

Open Date: 2017-10-01

Close Date: 2018-09-01

Grant: Close

The Role of Alternative Polyadenylation in Advanced Prostate Cancer

Open Date: 2017-09-01

Close Date: 2022-02-28

Articles (7)

Year:

2025

Aberrant microRNA expression is common in cancer, yet cell-type-specific microRNA activity in the tumor microenvironment (TME) remains poorly understood. Here, we show that germline deletion of miR-21 significantly attenuated the progression of MYC-driven prostate cancer (PCa), reducing prostate weight, tumor burden, and proliferation index in Hi-Myc mice. In situ hybridization revealed elevated miR-21 expression in multiple cell types during disease progression. Inflammatory and premalignant lesions in mouse and human prostate showed increased miR-21 in both stroma and epithelium, with further enrichment in the stroma of invasive adenocarcinoma. In Hi-Myc mice, single cell RNA-sequencing revealed miR-21 gene regulation in neoplastic, stromal, and immune cells in a cell-type-specific manner, impacting both direct and indirect targets. Notably, miR-21 deletion reduced immune infiltration into the prostate TME, particularly Trem2 -expressing macrophages and regulatory T cells. The Timp1-fibroblast gene signature in MYC-driven PCa was suppressed in miR-21 knockout prostates. Cell-cell communication analysis showed that miR-21 suppressed TGF-beta signaling in the TME, partially through Ski and Smad7 suppression in cancer-associated fibroblasts. These findings underscore the crucial role of miR-21 in PCa and provide some of the first in situ insights into cell-type-specific miRNA activity in solid tumors.

Year:

2025

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

W. Nathaniel Brennen

Associate Professor

Johns Hopkins University School of Medicine

UNITED STATES
View details

Srinivasan Yegnasubramanian

-

UNITED STATES
View details

Sudipto Ganguly

Assistant Professor

Johns Hopkins University

UNITED STATES
View details

Angelo De Marzo

Professor

Johns Hopkins University School of Medicine

UNITED STATES
View details

Sudath Hapuarachchige

Assistant Professor of Radiology and Radiological Science

Johns Hopkins University School of Medicine

UNITED STATES
View details